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Abstract
Skeletal muscle myopathy is universal in cirrhotic patients, however, little is
known about the main mechanisms involved. The study aims to investigate
skeletal muscle morphological, histological, and functional modifications in
experimental models of cirrhosis and the principal molecular pathways
responsible for skeletal muscle myopathy. Cirrhosis was induced by bile duct
ligation (BDL) and carbon tetrachloride (CCl4) administration in mice. Con-
trol animals (CTR) underwent bile duct exposure or vehicle administration
only. At sacrifice, peripheral muscles were dissected and weighed. Contractile
properties of extensor digitorum longus (EDL) were studied in vitro. Muscle
samples were used for histological and molecular analysis. Quadriceps muscle
histology revealed a significant reduction in cross-sectional area of muscle and
muscle fibers in cirrhotic mice with respect to CTR. Kinetic properties of EDL
in both BDL and CCl4 were reduced with respect to CTR; BDL mice also
showed a reduction in muscle force and a decrease in the resistance to fatigue.
Increase in myostatin expression associated with a decrease in AKT-mTOR
expressions was observed in BDL mice, together with an increase in LC3 pro-
tein levels. Upregulation of the proinflammatory citochines TNF-a and IL6
and an increased expression of NF-kB and MuRF-1 were observed in CCl4
mice. In conclusion, skeletal muscle myopenia was present in experimental
models of BDL and CCl4-induced cirrhosis. Moreover, reduction in protein
synthesis and activation of protein degradation were the main mechanisms
responsible for myopenia in BDL mice, while activation of ubiquitin-pathway
through inflammatory cytokines seems to be the main potential mechanism
involved in CCl4 mice.
Introduction
Muscle wasting is a characteristic feature of liver cirrhosis
(O’Brien and Williams 2008) . In spite being a significant
clinical complication in these patients, also affecting prog-
nosis, the mechanisms mediating muscle loss are not
completely known (Dasarathy 2012). Recently, elevated
plasma concentrations of myostatin, a negative regulator of
muscle mass, were reported in patients with cirrhosis
(Garcıa et al. 2010), while contradictory results have been
published on the expression of myostatin in muscle biopsy
obtained from cirrhotic patients (Merli et al. 2013; Qiu
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et al. 2013). The difficulty in obtaining muscle biopsy in
cirrhotic patients is one of the reasons why knowledge
about the pathophysiological mechanism of muscle wasting
is still scarce. Therefore, the use of animal models can be
fundamental. In the experimental model of liver atrophy
secondary to portocaval shunt, hyperammonemia, a fre-
quent alteration in liver cirrhosis, has been proposed as the
main trigger able to activate NF-kB inducing transcription
of myostatin (Qiu et al. 2013). In the same model, the
expression of ubiquitin-proteasome pathway was reported
to be unaltered, while the expression of autophagy markers
was found to be enhanced with respect to control animals
(Dasarathy et al. 2004, 2011, 2007; Qiu et al. 2012).
A multifactorial etiology for sarcopenia, secondary to
liver cirrhosis, is conceivable (O’Brien and Williams
2008) and the results obtained in the animal models with
portocaval shunt may not be completely representative of
the chronic metabolic alteration characteristic of liver cir-
rhosis. In experimental model of bile duct ligation (BDL),
tumor necrosis factor-a (TNF- a) has been suggested to
play a potential role in the pathogenesis of muscle wast-
ing mediating the activation of the ubiquitin-proteasome
pathway (Lin et al. 2005).
To the best of our knowledge, skeletal muscle mass
modification is still not well characterized in experimental
models of liver cirrhosis.
Therefore, the primary aim of this study was to charac-
terize, at morphological and functional levels, skeletal
muscle alterations secondary to liver cirrhosis induced in
mice by either BDL or carbon tetrachloride (CCl4)
administration. Secondarily, we identified possible molec-
ular pathways involved in the promotion of skeletal
muscle myopenia.
Material and Methods
The experiments were performed in 12-week-old male
wild-type (FVB) mice purchased from Charles River Lab-
oratories (Lecco, Italy). The mice were kept under con-
stant temperature and humidity in a 12-h controlled
dark⁄light cycle. All the experiments were conducted
within the animal welfare regulations and guidelines of
the Italian national law D.L. 04/03/2014, n.26, about the
use of animals for research.
Mice models of chronic liver disease
Common bile duct ligation
The surgical procedure was performed under sterile con-
ditions. Under tribromoethanol anesthesia, following a
median abdominal incision, bile duct was exposed and
then doubly ligated, once close to the liver hilus, once
2 cm below the liver hilus. The bile duct was then sec-
tioned between these two ligatures. Mice were sacrificed
at the end of 5 weeks of treatment by cervical dislocation.
During this period, animals were fed ad libitum with
standard food pellets (25/18 standard diet from Muce-
dola, Settimo, Milanese, Italy).
Administration of CCl4
Liver fibrosis was induced by intraperitoneal injection,
twice a week, of CCl4 0.2 mL/100 g in refined olive oil
(1:1) for 12 weeks according to a well-established model
(Domenicali et al. 2009). Mice were sacrificed at the end
of 12 weeks of treatment by cervical dislocation. During
this period, animals were fed ad libitum with standard
food pellets (25/18 standard diet from Mucedola, Settimo,
Milanese, Italy).
Control mice
Mice undergoing median abdominal incision and exposure
of the common bile duct without bile duct ligation repre-
sented the sham operated control for the BDL (CTR-BDL).
These animals were sacrificed after 5 weeks as the BDL.
Mice receiving intraperitoneal injections of vehicle only
twice a week represented the control group for mice trea-
ted with CCl4 (CTR-CCl4). These mice were sacrificed
after 12 weeks.
At sacrifice, the presence of ascites was evaluated in all
groups of animals and weighted using sterilized and
already weighed paper disks. Ascites was then subtracted
from the body weight to obtain the dry body weight.
Histopathology of the liver
The liver was removed, weighed and immediately fixed in
10% phosphate-buffered formalin and embedded in
paraffin. Connective tissue was quantified by Sirius Red
staining by analyzing liver sections with an Image Analysis
System (IAS; Delta Sistemi, Rome Italy) and the morpho-
logical changes were measured by haematoxylin–eosin
(H&E) staining. Intrahepatic bile duct mass (IBDM) was
quantified by immunohistochemistry for cytokeratin-19
(CK-19) (Mancinelli et al. 2010).
Skeletal muscle mass – histological and
histochemical analysis
Immediately after animal sacrifice, the two gastrocnemius,
quadriceps and tibialis muscles, were dissected and
weighed. One muscle of each group was snap frozen in
liquid nitrogen and stored at-80°C, while the contralateral
was used for the histological and histochemical analysis.
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Muscles were embedded in tissue freezing medium and
snap frozen in nitrogen-cooled isopentane. Sections of
muscle tissue were cut at 7 microns in a 28°C cryostat
and stained for hematoxylin and eosin (H&E). Morpho-
metric examination was carried out with a microscope at
109 and 209 magnification, connected to a computerized
image analysis system. Muscle cross-sectional area of the
quadriceps at its mid-portion was calculated and total
number of myofibers was counted. Boundaries of individ-
ual muscle fibers were delineated and fiber cross-sectional
area (CSA) was determined from the number of pixels
within the outlined fiber using Image Analysis System
(ImageJ 1.48). A minimum of four random fields (corre-
sponding to about 1000 cross-sectioned fibers) was pho-
tomicrographed for each quadriceps and mouse (>3
animals/groups).
Ex-vivo mice extensor digitorum longus
mechanical measurements
Extensor digitorum longus (EDL) muscle isolated from
the animal models above described was tested in vitro for
its functional properties, both in isometric and isotonic
conditions (Del Prete et al. 2008). Briefly, the muscle to
be tested was transferred to a temperature-controlled
chamber (30°C), containing a Krebs-Ringer solution equi-
librated with 5% CO2-95% O2. The proximal tendon was
fixed to an actuator/transducer (model Aurora Scientific
Instruments 300B).
The isolated muscle was electrically stimulated by means
of two platinum electrodes with 300 mA controlled current
pulses. Optimum muscle length was adjusted to the length
(L0) that produced the highest twitch force. Single pulse
stimulation was employed to evaluate the specimen’s
kinetic parameters, namely the maximum force derivative
for the contraction (df/dt) and the relaxation (df/dt)
phases of the muscle contraction. Maximum tetanic force
was measured with a train of pulses delivered at 180 Hz.
Specific force was computed as maximum force divided by
estimated muscle cross-sectional area (Brooks and Faulkner
1988). Muscle resistance to fatigue was evaluated in iso-
tonic conditions, allowing the specimen to shorten against
a load equal to one-third of its own maximum force.
RNA extraction and quantitative RT-PCR
Total RNA extraction from mice muscle tissue was per-
formed with tissue lyser (Qiagen) in TriRiagentTM
(Sigma). RNA was reverse-transcribed using a QuantiTect
Reverse Transcription kit (Qiagen). The reverse transcrip-
tion reactions were performed according to the manufac-
turers’ instructions. Quantitative PCR was performed on
an ABI PRISM 7500 SDS (Applied Biosystems, USA),
using pre-made 6-carboxyfluorescein (FAM)-labeled Taq-
Man assays for GAPDH, MuRF-1, Atrogin-1, Myostatin,
LC3 (Applied Biosystems). Quantitative RT-PCR sample
values were normalized to the expression of GAPDH
mRNA. The relative level for each gene was calculated
using the 2-DDCt method (Livak and Schmittgen 2001)
and reported as mean fold change in gene expression.
Protein extraction
Protein extraction from tissue muscle of BDL, CCl4, and
control mice was performed in Lysis Buffer (10 mmol/L
Tris, 150 mmol/L Sodium Chloride, 1% NP40, 0.1% SDS,
10% Glycerol, 1% Deoxycholate, 1 mmol/L Phenylmethyl-
sulfonyl Fluoride, 1 lg/mL Aprotinin, 1 lg/mL Leupeptin,
1 lg/mL Pepstatin, 1 mmol/L Sodium Orthovanadate, and
1 mmol/L Sodium Fluoride). Equal amounts of protein
from each lysate were separated in SDS polyacrilamide gel
and transferred onto a nitrocellulose membrane. Filters
were blotted over night (o.n.) with primary antibodies
diluted in TBST, after 5% milk saturation. Then, filters
were incubated with secondary antibodies anti-Rabbit o
anti-Mouse (IgG HRP-conjugated) (Bethyl, Montgomery,
TX. Cat. A120-201P) in 1% milk for 1 h. Signals were
acquired by ChemiDoc MP instrument (Bio-Rad, Hercules,
CA) and densitometric analysis was performed with Image
Lab acquisition analysis software (Bio-Rad). The expression
levels of each analyzed protein were calculated with respect
to control group and reported as mean fold change values.
Expression levels of the proteins of CTR-BDL and CTR-
CCl4 mice were superimposable and for that reason, the
two groups were considered together for the western blot
analysis. Protein level of actin was used as control for equal
protein loading. The following primary antibodies were
used: Phospho-Akt (Ser473) (D9E) XP (#4060) Cell Signal-
ing; Akt Antibody (#9272), Cell Signaling; Phospho-mTOR
(Ser2448) (#2971), Cell Signaling; mTOR (#2972), Cell Sig-
naling; Myostatin (sc-6885-R), Santa Cruz; Actin (A2066),
Sigma Aldrich; LC3B (#2775), Cell Signaling; NF-jB p65
(C22B4) (#4764), Cell Signaling; Phospho-NF-jB p65
(Ser536) (7F1) (#3036), Cell Signaling; MuRF1 (C-terminal
region) (MP3401), ECM Biosciences; Anti-SQSTM1 / p62
(ab56416), Abcam.
Statistical analysis
All data are expressed as mean  SEM. Statistical analysis
was performed with GraphPad Prism v 6.05 software;
Student’s unpaired t-test for parametric data and Mann–
Whitney–Wilcoxon test for nonparametric data were used
when two groups were compared. The difference between
the two groups was considered significant for P < 0.05.
Mann–Whitney Rank Sum test was used to compare fiber
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size frequency distributions. The difference in the median
values between the two groups was considered significant
for P < 0.05.
Results
Liver histology and muscles morphological
analysis in experimental groups
In this study, the mice typically developed liver cirrhosis/
ductular proliferation 12 weeks after CCl4 injection and
5 weeks after BDL, respectively, which was confirmed by
histological analysis (Table 1 and Fig. 1). No liver damage
or histological alteration was identified in CTR mice
(Fig. 1).
All CCl4 animals developed ascites at the end of
the treatment, while no ascites was present in the
BDL model. At sacrifice, ascites was estimated to be
0.135  0.020 mg.
The weight of total body, liver, spleen, lower extremi-
ties muscle, as well as the organ-to-body weight ratios are
Table 1. Evaluation of liver fibrosis and bile duct mass in experi-
mental groups.
Volume fraction
occupied by collagen
(sirius red stained) fibers BMD
CTR 1.9  0.21 0.28  0.05
BDL 5.4  1.11 4.18  0.21
CCl4 7.8  0.51 0.21  0.08
Values are mean  SEM.
BMD, bile duct mass; CTR, control; BDL, bile duct ligation; CCl4,
Carbon Tetrachloride. n ≥ 3.
1
P < 0.05 vs. CTR.
H&E Sirius Red CK19
C
T
R
B
D
L
C
C
14
Figure 1. Liver histology in experimental groups. Histology of liver sections showed enhanced fibrosis (evaluated by Sirius Red Staining) and an
increased intrahepatic bile duct mass (BDM) expressed by positive cytokeratin 19 in BDL and CCl4 mice with respect to their own controls. CTR,
control; BDL, bile duct ligation; CCl4, Carbon Tetrachloride.
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shown in Table 2. The initial body weights of CCl4 and
BDL animals were similar with respect to their controls
but at the end of the study, CCl4 animals tended to weigh
more than CTL-CCl4 ones, while BDL tended to weigh
less than their controls even if these modifications did
not reach statistical significance (P = 0.24 and P = 0.05,
respectively). The liver and spleen-body weight ratios
were significantly higher both in CCl4 animals and BDL
with respect to their controls. Muscle-to-body weight
ratio of the total lower extremities muscles was signifi-
cantly lower both in the CCl4 and BDL animals compared
with their controls. A significant reduction in muscles
weight was observed in gastrocnemius and quadriceps
muscles (Fig. 2).
To verify whether or not skeletal muscle myopenia
occurred in our experimental models, we carried out his-
tological analysis of skeletal muscles (Fig. 3). The average
cross-sectional area (CSA) of the quadriceps was signifi-
cantly reduced with respect to controls both in CCl4
(47% vs. CTR- CCl4) and in BDL (34% vs. CTR-
BDL) (Fig. 3A–B). The total myofiber number of quadri-
ceps of cirrhotic mice was also lower compared to con-
trols (Fig. 3C–D). The frequency distribution of muscle
fibers’ CSA revealed a shift toward a smaller size of mus-
cle fibers in mice treated with CCl4 and BDL, which was
more evident for CCl4 (Fig. 4). The results suggested the
development of a condition of skeletal muscle myopenia
in cirrhotic mice.
Table 2. Organ and muscle weights in experimental groups.
CTR-CCl4 CCl4 P CTR-BDL BDL P
Preoperative weight, g 27.96  0.63 26.61  0.60 0.18 29.67  0.67 29.26  0.41 0.79
Postoperative weight, g 29.04  1.15 31.26  0.91 0.24 30.48  0.78 27.53  1.20 0.05
Liver weight, mg 1.29  0.11 1.72  0.12 0.011 1.34  0.06 2.42  0.23 0.00081
Liver-to-body weight ratio 4.43  0.23 5.60  0.30 0.011 4.41  0.18 8.72  0.53 0.00021
Spleen weight, mg 0.144  0.02 0.148  0.005 0.49 0.154  0.01 0.268  0.02 0.00071
Spleen-to-body weight ratio 0.417  0.01 0.479  0.03 0.041 0.441  0.02 0.968  0.05 0.00011
Lower extremity muscles weight, mg 923.2  39.2 809.4  10.2 0.041 866.5  17.5 711.17  30.6 0.00331
Lower extremity muscles
weight-to-body weight ratio
3.13  0.11 2.59  0.06 0.0021 2.85  0.039 2.59  0.09 0.0311
Values are expressed as mean  SEM.
CTR, control; BDL, bile duct ligation; CCl4, Carbon Tetrachloride. n = 7.
1
P < 0.05 versus CTR.
Figure 2. Muscles weight in experimental groups. Measurements are presented as mean  SEM (##P < 0.01 vs CTL-CCl4; *P < 0.05 and
**P < 0.01 vs CTL-BDL).
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Functional performance and contractile
properties of skeletal muscles in
experimental groups: ex-vivo analysis
To determine whether liver cirrhosis affected the capacity
to produce force and the contractile properties of skeletal
muscles, a study of mechanical parameters was performed
on the EDL, a typical fast-type fiber muscle, of both BDL
and CCl4 mice and of their controls.
Among the functional parameters analyzed, we
observed a slowing down of the kinetic properties of EDL
muscle, as expressed by the dF/dt (Fig. 5A) and the dF/
dt (Fig. 5B). Of note, the BDL treatments induced more
Figure 3. Histological analysis of quadriceps from the experimental groups. (A) Haematoxylin and eosin-stained cross-sectional area of
quadriceps muscles at its mid-portion from the experimental groups. Bar = 10 lm. (B) Median values of quadriceps cross-sectional area from
the experimental groups (n ≥ 3); (C) Haematoxylin and eosin-stained cross-sections of myofiber of quadriceps muscles from the experimental
groups. Bar = 100 lm.; (D) The myofiber number of the quadriceps muscles from the experimental groups (n ≥ 3); (E–F) Fiber size of
quadriceps muscles in CTR-CCl4 (n ≥ 4) and CCl4 (n ≥ 4). Median values of fiber size. (Mann–Whitney Rank Sum test: P < 0.0001).
Measurements are presented as mean  SEM (#P < 0.05 and ##P < 0.01 vs. CTL-CCl4; *P < 0.05 and **P < 0.01 vs. CTL-BDL). CTR, control;
BDL, bile duct ligation; CCl4, Carbon Tetrachloride.
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severe functional alterations, compared with CCl4 treat-
ments, as revealed by the significant reduction in the teta-
nic force, the reduction in specific force, and by the
significant reduction in the time to fatigue (38%)
(Fig. 5C–E). No direct significant effects of CCl4 treat-
ment seems to appear in the specific force.
Characterization of the main molecular
pathways involved in liver cirrhosis-induced
myopathy
Myostatin, a member of TGF-b superfamily, has been iden-
tified to play a pivotal role in mediating muscle atrophy in
experimental models of liver damage. Western blot analysis
revealed over expression of myostatin in BDL versus CTR
while it was significantly reduced in CCl4 mice versus CTR
(Fig. 6A). Myostatin negatively regulates the activity of the
Akt-mTOR axis, which promotes protein synthesis. In our
models, a significant decrease in Akt expression and mTOR
was observed in BDL mice (Fig. 6B–C), while no modifica-
tion was observed in CCl4-treated mice.
Autophagy is responsible for controlled degradation of
cytoplasmic components, as well as providing essential
nutrients during starvation and stress to maintain cellular
homeostasis. Since cirrhosis is a state of accelerated star-
vation, enhanced muscle autophagy may serve as a source
of essential amino acids for critical cellular function. Key
components of this pathway include a cytosolic protein
(LC3-I), which is also modulated by myostatin expres-
sion, that is lapidated (LC3-II) to facilitate autophago-
some membrane formation, and p62/SQSTM1 that
targets cargo to the autophagosome for degradation. LC3
expression was increased in BDL mice and reduced in
CCl4 mice (Fig. 6D), while p62/SQSTM1 protein’s levels
were overexpressed in CCl4 mice but not in BDL
(Fig. 6E). These data suggested that other pathway, myo-
statin-independent, able to activate proteolytic mecha-
nisms were involved in muscle myopathy in CCl4 mice.
Expressions of inflammatory cytokines such as TNF-a
and IL-6 were evaluated. TNF-a has been shown to have
direct catabolic effect on skeletal muscle and produces
muscle atrophy through the upregulation of the
Figure 4. Frequency distribution of muscle fibers’ cross-sectional area of quadriceps from the experimental groups. A: CTR-CCl4 vs CCl4; CTR-
CCl4: 2903  22; CCl4: 2116  17, P < 0.0001; B: CTR-BDL vs BDL; CTR-BDL: 2990  17, BDL: 2774  17, P < 0.0001. Measurements are
presented as mean  SEM Abbreviations: CTR: control; BDL: bile duct ligation; CCl4: carbon tetrachloride.
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transcription factor NF-jB which activates transcription
of components of the ubiquitin–proteasome proteolytic
pathway such as atrogin-1 and MuRF-1. A significant
increase in TNF-a and IL-6 was observed in CCl4 mice,
while no modification was observed in BDL mice (Fig. 7A–
B). Accordingly pNF-kB expression, the activated form of
Figure 5. Physiological properties of extensor digitorum longus muscles from experimental groups. Functional performance and contractile
properties of extensor digitorum longus muscles were compared by dF/dt, dF/dt, tetanic force, specific force, and time to fatigue. All
measurements are presented as mean  SEM (#P < 0.05 vs. CTR-CCl4; *P < 0.05 vs. CTR-BDL); n ≥ 3; BDL, bile duct ligation; CCl4, Carbon
tetrachloride.
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NF-kB, was increased in CCl4 mice (Fig. 6F). MuRF-1
expression was also confirmed to be increased in CCl4 mice,
while it was unchanged in BDL models (Fig. 6G). Real-time
PCR showed reduction in Atrogin-1 transcription both in
CCl4 and BDL (Fig. 7C). We thus speculated that atrogin-1
expression can be partially repressed and other pathways
may be involved in the CCl4- and BDL-mediated muscle
atrophy. The first hypothesis is supported by the evidence
that PGC1 a, which increased in BDL muscles (Fig. 7D),
inhibits FoxO-dependent transcription on atrogin1 pro-
moter, thereby suppressing atrogin1 expression (Sandri
et al. 2006).
Discussion
With this study, we have characterized skeletal muscle
alterations secondary to liver cirrhosis in two different
experimental models. Common BDL is a model of
secondary biliary cirrhosis, and although it has been
mainly employed in rats (Alvaro et al. 2000; Mancinelli
et al. 2010), it has also been developed in mice (Chang
et al. 2005). As demonstrated by histological analysis per-
formed on liver sections, marked cholangiolar prolifera-
tion and expansive portal fibrosis was observed 5 weeks
after BDL in all the mice included in the study. In a
recent paper by Domenicali and colleagues, CCl4 adminis-
tration in mice has been proven to be a successful model
to establish a frank cirrhosis ensuring optimal results in
terms of reproducibility, tolerability, and time of induc-
tion (Domenicali et al. 2009). Indeed, after treatment, all
the animals included in this study showed a fully estab-
lished cirrhosis without significant differences in the
amount of liver fibrosis and all of them developed ascites.
Both BDL and CCl4-induced cirrhosis were characterized
by modifications in muscle mass. The decrease ratio of
muscle weight to body weight together with the histologi-
cal evidence of a reduction in the muscle CSA and muscle
fibers associated with a shift of fibers’ CSA toward smaller
size of muscle fibers are all evidences of the establishment
of a condition of myopenia. We therefore suggest that
both models can be employed to explore mechanism of
skeletal muscle myopenia secondary to liver cirrhosis.
It is well established that many patients with cirrhosis
experience decreased strength and increased fatigue of
skeletal muscle (Jones et al. 2012). This is mostly seen as
part of a poor nutritional status, enhanced catabolism, or
decreased protein synthesis, but specific investigations of
muscle function as well as of muscle composition in liver
cirrhosis are still lacking. Fatigue and muscle weakness
can depend on central or peripheral process: the clinical
expression of fatigue and muscle strength encompasses
complex interactions with biological, psychosocial, and
behavioral processes (Allen et al. 2008). For these reasons,
in human study, it is extremely difficult to differentiate at
which points weakness arises. Experimental models and,
most of all, the availability of isolated muscle tissue offer
the opportunity to investigate pathological mechanism
responsible for muscle fatigue and weakness directly. Data
actually available on this argument in models of liver cir-
rhosis are still insufficient. Previous experimental studies
have described nonspecific histology changes in skeletal
muscle, most often myocytolysis, with variation in fiber
size and type II fiber atrophy (Gayan-Ramırez et al.
1998). However, most of the studies were mainly related
to alcohol myopathy that is probably characterized by
specific alterations. In contrast, the association between
myopathy and nonalcoholic liver cirrhosis is less well doc-
umented (Gayan-Ramırez et al. 1998; Lopez-Lirola et al.
2003; Weber et al. 1992), and the possible pathogenesis is
poorly understood. In a study by Ramirez and colleagues,
diaphragm and peripheral muscle mass in BDL cirrhotic
Figure 7. Expression of myogenic genes in experimental groups.
Real-time PCR analysis for the expression of TNF a (F), IL-6 (G)
Atrogin-1 (L), and PGC1- a (M) on tissue muscle of BDL, CCL4, and
control mice. Data are represented as mean  SEM; n = 3–6 per
group. **P < 0.005; *P < 0.05 between BDL and control group;
##P < 0.005; #P < 0.05 between CCl4 and control group (by Mann–
Whitney test). BDL, bile duct ligation; CCl4, Carbon Tetrachloride.
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rats were decreased and a clear reduction in the cross-sec-
tional area of type IIx/b muscle fiber was also present in
both diaphragm and gastrocnemius. However, no changes
in diaphragm force nor in its endurance were observed
(Gayan-Ramırez et al. 1998). Type IIb fiber atrophy was
also reported by Weber et al. (1992) in diaphragm sec-
tions of rat model in which liver damage was induced by
CCl4 administration. Similar results were achieved by
Lopez-Lirola et al. (2003)who found that muscle atrophy
ensues in carbon tetrachloride-treated rats, especially IIa
fiber atrophy, but only when protein deficiency was also
present, suggesting that fiber atrophy was predominantly
as a consequence of malnutrition but not of cirrhosis
itself. In all these studies, functional analysis was not per-
formed. In our study, the evaluation of the functional
performance and the contractile properties of skeletal
muscles, performed on EDL, revealed significant
alterations of muscle functional parameters in both mod-
els of liver damage. BDL compromised both muscle force
and muscle contraction velocity, while cirrhosis secondary
to CCl4 administration compromised the contraction
velocity without affecting muscle force. These data, sug-
gest that BDL and CCl4 secondary cirrhosis are both asso-
ciated with the development of skeletal muscle myopenia
but the functional characteristics of muscle impairment is
different in the two models.
The pathogenesis of muscle myopenia has also been
investigated. Previous studies on experimental models of
hyperammonemia or portocaval shunt in rats have
demonstrated that the predominant mechanism of muscle
depletion in these disorders were the increased activation
of NF-kB p65, with a subsequent higher expression of
myostatin, a negative regulator of skeletal muscle mass
(Qiu et al. 2013).
Figure 8. Molecular pathways in experimental groups. A summary of the molecular pathways responsible for skeletal muscle atrophy in the
different experimental models of cirrhosis are described here. BDL, bile duct ligation; CCl4, Carbon Tetrachloride.
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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Moreover, muscle wasting was associated with activa-
tion of autophagic pathways, while proteolytic pathways
were found to be involved in the early phase of liver
damage in association with a reduction in the expression
of IGF-1, a positive regulator of muscle mass (Dasarathy
et al. 2004, 2011, 2007).
However, no evidence of the pathological mechanism
responsible for muscle mass modifications in other mod-
els is actually available. In our study, we tried to evaluate
potential pathways involved in skeletal muscle myopathy.
The reduction in the muscle cross-sectional area of trea-
ted mice would be expected to activate relevant gene
involved in the induction of muscle atrophy such as
MAFbx/Atrogin-1 and MuRF-1 (Sandri et al. 2004). Sur-
prisingly, quantitative reverse transcription polymerase
chain reaction (RT-PCR) analysis revealed that while
MuRF-1 expression increased in CCl4 and BDL compared
to CTR mice, atrogin-1 was downregulated. We extended
the study by analyzing several other factors that can mod-
ulate these factors and therefore muscle atrophy. We thus
speculated that Atrogin-1 expression can be partially
repressed and/or other pathways may be involved in the
CCl4-and BDL-mediated muscle atrophy. The first
hypothesis is supported by the evidence that PGC1 a,
which increased in BDL muscles, inhibits FoxO-depen-
dent transcription on Atrogin-1 promoter, thereby sup-
pressing atrogin-1 expression (Sandri et al. 2006). We
also defined the critical and specific mediators and signal-
ing activated by the two distinct treatments, namely CCl4
and BDL that might trigger muscle atrophy. Interestingly,
we demonstrated that BDL activates myostatin, a negative
modulator of muscle mass, which also negatively regulates
the activity of the Akt pathway (Rodriguez et al. 2014).
Indeed, we also demonstrated a selective down modula-
tion of the Akt, a kinase essential to promote protein syn-
thesis and cell survival and to block protein degradation,
and of the mTOR, which is an important mediator for
the positive control of protein synthesis and the mainte-
nance of the differentiated myogenic phenotype. In addi-
tion, we observed an upregulation of LC3, a molecular
marker of autophagic pathway, which is also modulated
by myostatin expression (Rodriguez et al. 2014). The lack
of p62 upregulation suggests that BDL induce an accumu-
lation of autophagosomes, which however do not fuse
with lysosomes. Conversely, CCl4 activates alternative
pathways. We observed a selective upregulation of TNF-a
and IL-6, two cytokines which activate NF-kB, a signaling
pathway linked to several pathologic processes in skeletal
muscle (Bar-Shai et al. 1057). NF-kB, in turn maintains
upregulated IL-6, contributing to activate the inflamma-
tion amplifier and therefore exacerbating the atrophic
phenotype. Of note, we also analyzed NF-kB based on the
interesting evidence that it induces muscle atrophy and
wasting, upregulating MuRF-1 but not Atrogin-1 (Cai
et al. 2004; Mourkioti et al. 2006). Interestingly, it has
been also reported that p62, which we observed upregu-
lated in CCl4 muscle, can promote the expression of
inflammatory genes via NF-kB (Moscat and Diaz-Meco
2009). The main molecular pathways responsible for
skeletal muscle myopenia in the two different experimen-
tal models of cirrhosis are summarized in Figure 8. The
main shortcoming of our study was the lack of a pair-
fed controls for both BDL and CCl4 mice; nevertheless,
all the animals received a similar diet, so the effect
of malnutrition/protein deficiency per se could not be
assessed. Moreover the inclusion of time-course experi-
ments and of gender as additional key parameter would
have added information on the dynamic process leading
to skeletal muscle myopenia and on the different feature
of muscle wasting among gender usually observed in
clinical study.
In conclusion, in our study, we observed skeletal mus-
cle myopenia in both the experimental models, reduction
in protein synthesis and activation of protein degradation
are the main mechanisms responsible for myopenia in
BDL mice, while activation of ubiquitin-pathway through
inflammatory cytokines seems to be the main potential
mechanism involved in CCl4 mice.
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